Zobrazeno 1 - 2
of 2
pro vyhledávání: '"F. D. Costanzo"'
Autor:
G. Colucci, R. Labianca, F. D. Costanzo, V. Gebbia, G. Cartenì, B. Massidda, E. Dapretto, L. Manzione, E. Piazza, M. Sannicolò, M. Ciaparrone, L. Cavanna, F. Giuliani, E. Maiello, A. Testa, P. Pederzoli, C. Gallo, M. D. Maio, F. Perrone, G. O. Italia Meridionale, G. I. per lo Studio dei Carcinomi dell'Apparato Digerente, G. O. Italiano di Ricerca Clinica, FALCONI , MASSIMO
Publikováno v:
Journal of Clinical Oncology. 28:1645-1651
Purpose Single-agent gemcitabine became standard first-line treatment for advanced pancreatic cancer after demonstration of superiority compared with fluorouracil. The Gruppo Italiano Pancreas 1 randomized phase III trial aimed to compare gemcitabine
Autor:
Andrea Bonacchi, Miccinesi G, Guazzini M, Rossi A, Bacci S, Toccafondi A, Martire M, Bellotti L, Perfetto R, Catanzaro P, Adamo V, Cascinu S, Doni L, Di Costanzo F, Rosselli M
Publikováno v:
Europe PubMed Central
Background There is an increase in the attention to factors influencing the quality of life of cancer patients. The aim of the present study was to evaluate temperament and character traits related to health-related quality of life (HRQoL) in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b01e537023f83853832718912b54b3fa